Mirion, a global leader in radiation safety, science, and medicine, has announced the debut of its new InstadoseVUE personal dosimeter at the 2023 Radiological Society of North America (RSNA) Meeting in Chicago. The InstadoseVUE features a display screen for improved user engagement and compliance and allows wearers to capture personalized dose reads on-demand using Bluetooth Low Energy Technology. The dosimeter also has programmable calendar features for easy scheduling of automatic dose reads. Mirion will showcase other industry-leading solutions at the RSNA, including CT QA, analysis software, thyroid uptake systems, and medical imaging tables. The company also recently welcomed ec-2 Software Solutions, expanding its Nuclear Medicine and Molecular Imaging Portfolio. Mirion CEO, Thomas Logan, expressed excitement about the acquisition and the company's commitment to leveraging ionizing radiation to support healthcare innovation. The Mirion Medical booth at the RSNA will provide insights and demonstrations of the company's products. Mirion is a global company headquartered in Atlanta and operates in 12 countries.
Mon, 27 Nov 2023 13:53:20 GMT | Marketscreener.com